ALNY vs DOCS · P/E 76, rev $2.25B vs P/E 21, rev $570.4M
Alnylam Pharmaceuticals Inc (ALNY) versus Doximity Inc (DOCS) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Doximity Inc (DOCS) is a health information services company listed on US.
Latest reported ALNY revenue for 2024-12-31 was $2.25B. Net income was -$278.2M. Revenue was up 23.0% from 2023-12-31 to 2024-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
Not investment advice. Open the ALNY and DOCS stock pages for the full models.
Not investment advice.